Lercanidipine Hydrochloride Generics [uk]

Lercanidipine Hydrochloride, the active ingredient in Lercanidipine Hydrochloride Generics [uk], is a dihydropyridine calcium channel blocker presented as an oral tablet for oral use. It is prescribed to lower elevated blood pressure in adults with hypertension.

GNH USA supplies Lercanidipine Hydrochloride Generics [uk] as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lercanidipine Hydrochloride is used to manage conditions within the hypertension disease family, providing blood pressure control through vascular smooth‑muscle relaxation.

- Essential hypertension: reduces systolic and diastolic pressure to target levels. - Isolated systolic hypertension: lowers elevated systolic pressure, especially in older patients. - Hypertension in elderly patients: offers once‑daily dosing with a favorable tolerability profile.

Lercanidipine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: sensation of warmth, especially on the face. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness. - Tachycardia: increased heart rate. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzymes. - Allergic reactions: rash, itching, or urticaria. - Angioedema: swelling of lips, tongue, or throat. - Life‑threatening arrhythmias: irregular heart rhythms.

When prescribing or dispensing Lercanidipine Hydrochloride, consider the following safety measures.

- Blood pressure monitoring: check regularly to avoid excessive lowering. - Discontinuation: do not stop abruptly without medical advice. - Hepatic impairment: use with caution; dose adjustment may be required. - Severe aortic stenosis: avoid or use only under specialist supervision. - Elderly patients: start at the lowest effective dose. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lercanidipine Hydrochloride can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels. - Concomitant antihypertensives (e.g., ACE inhibitors, ARBs): risk of additive hypotension. - Grapefruit juice: can elevate drug concentration.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Diuretics: may enhance blood‑pressure‑lowering effect. - Beta‑blockers: monitor for excessive heart‑rate reduction. - NSAIDs: may blunt antihypertensive response. - Lithium: monitor lithium levels for potential increase.